What is this study investigating:

This study is exploring an oral investigational medication for the treatment of Fibromyalgia.

Why is this study being conducted:

Current treatments for Fibromyalgia provide modest relief of symptoms and are marked with common side effects. This study explores a new treatment to test its effects and side effects in the treatment of Fibromyalgia.

Logistics:

• 3-month study duration
• 7 in-person clinic visits over the three month period
• Medication and/or placebo provided at no expense

You may qualify if:

• You are 18 to 80 years of age
• Are currently suffering from widespread pain or have been diagnosed with Fibromyalgia